Employer-based Insurance Coverage Increases Utilization of Planned Oocyte Cryopreservation

Overview

Journal J Assist Reprod Genet

Publisher Springer

Specialties Genetics
Reproductive Medicine

Date 2022 May 10

PMID 35536381

Authors

Arielle S Yeshua

Baruch Abittan

Liron Bar-El

Christine Mullin

Randi H Goldman

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine the utilization of planned oocyte cryopreservation (OC) in the year immediately prior to, and the year of, insurance coverage commencement for employees at our institution.

Methods: Patient demographics and cycle outcomes were retrospectively compared between the first OC cycles occurring in 2017 vs. 2018 according to insurance coverage and type, age, and the number of oocytes retrieved and cryopreserved. Continuous demographic variables including age, BMI, day 3 FSH and E2, AMH, gravidity, and parity were compared using student T-tests. Cycle outcomes, including the number of oocytes retrieved and cryopreserved were compared using linear regression models, adjusting for potential confounders including age, BMI, and ovarian reserve parameters.

Results: Between January 2017 and December 2018, 123 patients underwent planned OC at our institution. Patient age ranged from 23 to 44 years and did not significantly differ from 2017 to 2018 (mean 34.9 vs. 35.2). There was a 12% increase in planned OC utilization from 2017 (N = 58) to 2018 (N = 65). Significantly, more patients had any insurance coverage in 2018 vs. 2017 (71.9% vs. 40.4%, p = 0.001), a 78% increase. From 2017 to 2018, the number of patients with hospital-based insurance coverage undergoing planned OC increased by a factor of 8 (5 to 41.5%, p < 0.001), while the number of self-pay patients significantly decreased (p = 0.001). No differences were found regarding cycle outcomes.

Conclusion: A greater proportion of women at our institution had insurance coverage for planned OC in 2018 vs. 2017. Employer-based insurance coverage for planned OC was associated with a significant increase in utilization by hospital employees.

Citing Articles

Infertility treatment and offspring blood pressure-a systematic review and meta-analysis.

Yeung E, Trees I, Clayton P, Polinski K, Livinski A, Putnick D Hum Reprod Update. 2024; 31(1):2-20.

PMID: 39375871 PMC: 11696704. DOI: 10.1093/humupd/dmae029.

The Status of Fertility Preservation (FP) Insurance Mandates and Their Impact on Utilization and Access to Care.

Sauerbrun-Cutler M, Rollo A, Gadson A, Eaton J J Clin Med. 2024; 13(4).

PMID: 38398385 PMC: 10889224. DOI: 10.3390/jcm13041072.

Racial Disparities in Fertility Care: A Narrative Review of Challenges in the Utilization of Fertility Preservation and ART in Minority Populations.

Gadson A, Sauerbrun-Cutler M, Eaton J J Clin Med. 2024; 13(4).

PMID: 38398373 PMC: 10889491. DOI: 10.3390/jcm13041060.

Oocyte Cryopreservation for Medical and Planned Indications: A Practical Guide and Overview.

Han E, Seifer D J Clin Med. 2023; 12(10).

PMID: 37240648 PMC: 10218997. DOI: 10.3390/jcm12103542.

References

Rashedi A, de Roo S, Ataman L, Edmonds M, Silva A, Scarella A . Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe. JCO Glob Oncol. 2020; 6. PMC: 7853877. DOI: 10.1200/JGO.2016.008144. View

Stoop D, van der Veen F, Deneyer M, Nekkebroeck J, Tournaye H . Oocyte banking for anticipated gamete exhaustion (AGE) is a preventive intervention, neither social nor nonmedical. Reprod Biomed Online. 2014; 28(5):548-51. DOI: 10.1016/j.rbmo.2014.01.007. View

Heck K, Schoendorf K, Ventura S, Kiely J . Delayed childbearing by education level in the United States, 1969-1994. Matern Child Health J. 1997; 1(2):81-8. DOI: 10.1023/a:1026218322723. View

Cobo A, Meseguer M, Remohi J, Pellicer A . Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010; 25(9):2239-46. DOI: 10.1093/humrep/deq146. View

Mertes H, Pennings G . Elective oocyte cryopreservation: who should pay?. Hum Reprod. 2011; 27(1):9-13. DOI: 10.1093/humrep/der364. View

Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N . What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility?. Fertil Steril. 2013; 100(5):1343-9. DOI: 10.1016/j.fertnstert.2013.07.201. View

Cobo A, Kuwayama M, Perez S, Ruiz A, Pellicer A, Remohi J . Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril. 2007; 89(6):1657-64. DOI: 10.1016/j.fertnstert.2007.05.050. View

Parmegiani L, Cognigni G, Bernardi S, Cuomo S, Ciampaglia W, Infante F . Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod Biomed Online. 2011; 23(4):505-12. DOI: 10.1016/j.rbmo.2011.07.003. View

Matthews T, Hamilton B . Delayed childbearing: more women are having their first child later in life. NCHS Data Brief. 2009; (21):1-8. View

10.

Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E . Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod. 2009; 25(1):66-73. PMC: 2794665. DOI: 10.1093/humrep/dep346. View

11.

Zoll M, Mertes H, Gupta J . Corporate giants provide fertility benefits: have they got it wrong?. Eur J Obstet Gynecol Reprod Biol. 2015; 195:A1-A2. DOI: 10.1016/j.ejogrb.2015.10.018. View

12.

Nybo Andersen A, Wohlfahrt J, Christens P, Olsen J, Melbye M . Maternal age and fetal loss: population based register linkage study. BMJ. 2000; 320(7251):1708-12. PMC: 27416. DOI: 10.1136/bmj.320.7251.1708. View

13.

Mertes H . Does company-sponsored egg freezing promote or confine women's reproductive autonomy?. J Assist Reprod Genet. 2015; 32(8):1205-9. PMC: 4554384. DOI: 10.1007/s10815-015-0500-8. View

14.

Ajala T, Rafi J, Larsen-Disney P, Howell R . Fertility preservation for cancer patients: a review. Obstet Gynecol Int. 2010; 2010:160386. PMC: 2850134. DOI: 10.1155/2010/160386. View

15.

Hook E . Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol. 1981; 58(3):282-5. View

16.

Cobo A, Perez S, de Los Santos M, Zulategui J, Domingo J, Remohi J . Effect of different cryopreservation protocols on the metaphase II spindle in human oocytes. Reprod Biomed Online. 2008; 17(3):350-9. DOI: 10.1016/s1472-6483(10)60218-0. View

17.

Sauer M, Paulson R, Lobo R . Pregnancy after age 50: application of oocyte donation to women after natural menopause. Lancet. 1993; 341(8841):321-3. DOI: 10.1016/0140-6736(93)90132-z. View

18.

. Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion. Fertil Steril. 2018; 110(6):1022-1028. DOI: 10.1016/j.fertnstert.2018.08.027. View

19.

Inhorn M, Birenbaum-Carmeli D, Westphal L, Doyle J, Gleicher N, Meirow D . Medical egg freezing: How cost and lack of insurance cover impact women and their families. Reprod Biomed Soc Online. 2018; 5:82-92. PMC: 6024226. DOI: 10.1016/j.rbms.2017.12.001. View

20.

Quinn G, Vadaparampil S, Bell-Ellison B, Gwede C, Albrecht T . Patient-physician communication barriers regarding fertility preservation among newly diagnosed cancer patients. Soc Sci Med. 2007; 66(3):784-9. DOI: 10.1016/j.socscimed.2007.09.013. View